Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company that discovers, develops and commercializes pharmaceutical products for the treatment of serious medical conditions. As of December 31, 2008, the Company had one marketed product: ARCALYST (rilonacept) Injection for Subcutaneous Use, which is available for prescription in the – more... United States for the treatment of cryopyrin-associated periodic syndromes (CAPS), including familial cold auto-inflammatory syndrome (FCAS) and muckle-wells syndrome (MWS) in adults and children aged 12 and older. Regeneron also has six clinical development programs, including three late-stage clinical programs. Its late-stage programs are aflibercept (VEGF Trap), which is being developed in oncology in collaboration with the sanofi-aventis Group; VEGF Trap-Eye, which is being developed in eye diseases using intraocular delivery in collaboration with Bayer HealthCare LLC, and ARCALYST, which is being developed for the treatment of gout.
(Source: 10-K) – less – More from ZoomInfo »
Regeneron Pharmaceuticals Jobs
Regeneron Pharmaceuticals Employer Reviews
Working at Regeneron Pharmaceuticals
What are the average starting salaries, bonuses, benefits and travel requirements like at Regeneron Pharmaceuticals?
What do you like best about working at Regeneron Pharm...
Do you work at Regeneron Pharmaceuticals? How did you find the job? How did you get that first interview?
Any advice for someone trying to get in?
It's always hard to know what to expect when going in for that interview -- and preparation can make all the difference. What is the interview process like at Regeneron Ph...
Every business has its own style. What is the office environment and culture like at Regeneron Pharmaceuticals?
Are people dressed in business casual, jeans and t-shirts,...
What do you think - will Regeneron Pharmaceuticals grow fast? Are they expanding their staff? How does Regeneron Pharmaceuticals stack up against the competition?
